iSpecimen prices $5M stock offering at $1.30; shares fall 18%
What's the deal? iSpecimen (NASDAQ:ISPC) has priced a public offering of roughly $5 million in common stock and pre-funded warrants. The price is $1.30 per share, or $1.2999 per pre-funded warrant. Shares fell 18% in premarket trading on the news.
What's the money for? iSpecimen said it will use proceeds to repay outstanding liabilities, pursue potential acquisitions, and invest in technology, marketing and advertising. Remaining funds will go towards working capital and general corporate purposes.
Why now? The raise follows the company's approximately $2.5 million private placement in May 2026, roughly doubling that amount.
What could go wrong? The share drop signals investor concern over dilution. The offering price of $1.30 sits below where the stock traded, and issuing new equity and warrants expands the share count.
The signal: Small-cap companies leaning on post-IPO equity to cover liabilities and fund expansion often trade near-term dilution for balance-sheet breathing room. For iSpecimen, the $5 million buys runway; the market's reaction shows the cost.
Read more: Seeking Alpha
Image credit: US Army Africa
